Software

View All
X's New "Edited" Image Labels Are a Mess Waiting to Happen - Professional coverage
AIPrivacySoftware

X’s New “Edited” Image Labels Are a Mess Waiting to Happen

According to TechCrunch, Elon Musk has teased a new feature for X that will label "edited visuals," resharing an announcement…

Why 95% of AI Projects Fail and How to Actually Scale Them - Professional coverage
AIInnovationSoftware

Why 95% of AI Projects Fail and How to Actually Scale Them

According to VentureBeat, organizations are stuck in "proof-of-concept purgatory" with AI, with MIT research estimating a staggering 95% of enterprise…

Meta Pulls the Plug on Teen AI Chatbots - Professional coverage
AIPrivacySoftware

Meta Pulls the Plug on Teen AI Chatbots

According to Futurism, Meta announced on Friday that it is cutting off teenagers' access to its AI chatbot characters, starting…

BusinessManufacturingTechnology

Boston Scientific Boosts Annual Profit Outlook on Robust Cardiac Device Sales

Boston Scientific has elevated its annual profit projections after exceeding third-quarter estimates, driven by substantial growth in heart device sales. The company’s electrophysiology segment saw a 23.1% year-over-year surge, with its stroke prevention and cardiac rhythm technologies performing particularly well. Despite facing regulatory and tariff challenges, the medical device manufacturer anticipates continued margin expansion.

Strong Cardiac Device Performance Drives Forecast Revision

Boston Scientific has reportedly raised its full-year profit guidance following better-than-expected third-quarter results, according to recent financial reports. The medical device manufacturer’s shares increased approximately 4.1% after the announcement, reflecting positive market response to the company’s performance and outlook.